DUBLIN--(BUSINESS WIRE)--Aug 28, 2018--The "Metastatic Hormone Refractory Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

Metastatic Hormone Refractory Prostate Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 report provides comprehensive insights about marketed and Phase III products for Metastatic Hormone Refractory Prostate Cancer.

The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. Coverage of API manufacturers for Metastatic Hormone Refractory Prostate Cancer marketed products spanning across United States, Europe, China and India. The manufacturers' details include manufacturers' names along with their locations.

This report provides a comprehensive understanding of the emerging Phase III therapies for Metastatic Hormone Refractory Prostate Cancer which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.

Key Topics Covered:

1. Report Introduction

2. Metastatic Hormone Refractory Prostate Cancer: Overview

3. Comparative Analysis of Marketed and Emerging Products

4. Marketed Therapies

5. Emerging Therapies (Phase III)

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/bswwxb/metastatic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180828005839/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Prostate Cancer Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL CONSUMER MEN

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/28/2018 04:59 PM/DISC: 08/28/2018 04:59 PM

http://www.businesswire.com/news/home/20180828005839/en